Abstract
hLDH5 plays a key role in the glycolytic metabolic switch found in invasive tumours and is now considered as a promising therapeutic target in cancer. Here we report a series of new hLDH5-inhibitors based on triazole-containing N-hydroxyindol-2-carboxylates, whose synthesis includes the highly reliable and simple "click chemistry" reaction.
Original language | English (US) |
---|---|
Pages (from-to) | 638-643 |
Number of pages | 6 |
Journal | MedChemComm |
Volume | 2 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2011 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry